P21WAF1/Cip1 limits senescence and acinar-to-ductal metaplasia formation during pancreatitis

Journal of Pathology

Volumn 235, Issue 3, 2015, Pages 502-514

  Grabliauskaite, Kamile ^a   Hehl, Adrian B ^b   Seleznik, Gitta M ^a   Saponara, Enrica ^a   Schlesinger, Kathryn ^a   Zuellig, Richard A ^a   Dittmann, Anja ^a   Bain, Martha ^a   Reding, Theresia ^a   Sonda, Sabrina ^a   Graf, Rolf ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

ADM; P21; Pancreatitis; Senescence; catenin

Indexed keywords

BETA CATENIN; CERULETIDE; PROTEIN P21; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ACINAR CELL; ACINAR TO DUCTAL METAPLASIA; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; METAPLASIA; MOUSE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; UPREGULATION; WILD TYPE; ANIMAL; CELL AGING; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; PANCREAS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION;

ANIMALS; BETA CATENIN; CELL AGING; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CERULETIDE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE MODELS, ANIMAL; DOWN-REGULATION; IN VITRO TECHNIQUES; METAPLASIA; MICE; MICE, KNOCKOUT; PANCREAS; PANCREATITIS; REGENERATION;

EID: 84920747937     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4440     Document Type: Article

References (63)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Jensen JN, Cameron E, Garay MV, et al. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 2005; 128: 728-741.
3. Fendrich V, Esni F, GarayMV, et al. Hedgehog signaling is required for effective regeneration of exocrine pancreas. Gastroenterology 2008; 135: 621-631.
4. Reichert M, Rustgi AK. Pancreatic ductal cells in development, regeneration, and neoplasia. J Clin Invest 2011; 121: 4572-4578.
5. De La OJ, Emerson LL, Goodman JL, et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci USA 2008; 105: 18907-18912.
6. Jim Leu SJ, Sung JS, Chen MY, et al. The matricellular protein CCN1 suppresses lung cancer cell growth by inducing senescence via the p53/p21 pathway. J Cell Biochem 2013; 114: 2082-2093.
7. Poulsen RC, Watts AC, Murphy RJ, et al. Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence. Ann Rheum Dis 2014; 73: 1405-1413.
8. Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 2000; 1471: M43-56.
9. Caldwell ME, DeNicola GM, Martins CP, et al. Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer. Oncogene 2012; 31: 1599-1608.
10. Morton JP, Timpson P, Karim SA, et al. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 2010; 107: 246-251.
11. Chen J, Amos CI, Merriman KW, et al. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. Pancreas 2010; 39: 1-4.
12. Dergham ST, Dugan MC, Joshi US, et al. The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma. Cancer 1997; 80: 372-381.
13. Silva A,Weber A, Bain M, et al. COX-2 is not required for the development of murine chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2011; 300: G968-975.
14. Graf R, Schiesser M, Lussi A, et al. Coordinate regulation of secretory stress proteins (PSP/reg, PAP I, PAP II, and PAP III) in the rat exocrine pancreas during experimental acute pancreatitis. J Surg Res 2002; 105: 136-144.
15. Algul H, Wagner M, Lesina M, et al. Overexpression of ErbB2 in the exocrine pancreas induces an inflammatory response but not increased proliferation. Int J Cancer 2007; 121: 1410-1416.
16. Jia D, Sun Y, Konieczny SF. Mist1 regulates pancreatic acinar cell proliferation through p21 CIP1/WAF1. Gastroenterology 2008; 135: 1687-1697.
17. Cozar-Castellano I, Haught M, Stewart AF. The cell cycle inhibitory protein p21cip is not essential for maintaining β-cell cycle arrest or β-cell function in vivo. Diabetes 2006; 55: 3271-3278.
18. 1 checkpoint control. Cell 1995; 82: 675-684.
19. Brugarolas J, Chandrasekaran C, Gordon JI, et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995; 377: 552-557.
20. Martin-Caballero J, Flores JM, Garcia-Palencia P, et al. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 2001; 61: 6234-6238.
21. Kowalik AS, Johnson CL, Chadi SA, et al. Mice lacking the transcription factorMist1 exhibit an altered stress response and increased sensitivity to caerulein-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1123-1132.
22. Pin CL, Rukstalis JM, Johnson C, et al. The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity. J Cell Biol 2001; 155: 519-530.
23. Bjorkoy G, Lamark T, Brech A, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171: 603-614.
24. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 2006; 66: 95-106.
25. Wielenga VJ, Smits R, Korinek V, et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999; 154: 515-523.
26. Li Y, Kong D, Ahmad A, et al. Pancreatic cancer stem cells: emerging target for designing novel therapy. Cancer Lett 2012.
27. Immervoll H, Hoem D, Steffensen OJ, et al. Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers. J Histochem Cytochem 2011; 59: 441-455.
28. De Lisle RC, Logsdon CD. Pancreatic acinar cells in culture: expression of acinar and ductal antigens in a growth-related manner. Eur J Cell Biol 1990; 51: 64-75.
29. 2 /M transition. Mol Biotechnol 2006; 32: 227-248.
30. Draetta G, Eckstein J. Cdc25 protein phosphatases in cell proliferation. Biochim Biophys Acta 1997; 1332: M53-63.
31. Hoffmann I, Clarke PR, Marcote MJ, et al. Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J 1993; 12: 53-63.
32. Morris JPt, Cano DA, Sekine S, et al. β-Catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J Clin Invest 2010; 120: 508-520.
33. KeefeMD,Wang H, De La OJ, et al. β-Catenin is selectively required for the expansion and regeneration of mature pancreatic acinar cells in mice. Dis Model Mech 2012; 5: 503-514.
34. Heiser PW, Cano DA, Landsman L, et al. Stabilization of β-catenin induces pancreas tumor formation. Gastroenterology 2008; 135: 1288-1300.
35. Kim NH, Kim HS, Kim NG, et al. p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci Signal 2011; 4: ra71.
36. Lee KH, Li M, Michalowski AM, et al. A genome-wide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc Natl Acad Sci USA 2010; 107: 69-74.
37. Okayama S, Kopelovich L, Balmus G, et al. p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression. J Biol Chem 2014; 289: 6513-6525.
38. Sadot E, Geiger B, Oren M, et al. Down-regulation of β-catenin by activated p53. Mol Cell Biol 2001; 21: 6768-6781.
39. Carreras Puigvert J, von Stechow L, Siddappa R, et al. Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells. Sci Signal 2013; 6: ra5.
40. Kim H. Cerulein pancreatitis: oxidative stress, inflammation, and apoptosis. Gut Liver 2008; 2: 74-80.
41. Rogakou EP, Pilch DR, Orr AH, et al. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273: 5858-5868.
42. Kong Y, Cui H, Ramkumar C, et al. Regulation of senescence in cancer and aging. J Aging Res 2011; 2011: 963172.
43. Kuilman T, Michaloglou C, Mooi WJ, et al. The essence of senescence. Genes Dev 2010; 24: 2463-2479.
44. Davalos AR, Coppe JP, Campisi J, et al. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metast Rev 2010; 29: 273-283.
45. Beausejour CM, Krtolica A, Galimi F, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22: 4212-4222.
46. Klimova TA, Bell EL, Shroff EH, et al. Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS. FASEB J 2009; 23: 783-794.
47. Pinho AV, Rooman I, Reichert M, et al. Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis. Gut 2011; 60: 958-966.
48. Lee KE, Bar-Sagi D. Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells. Cancer Cell 2010; 18: 448-458.
49. Perucca P, Cazzalini O, Madine M, et al. Loss of p21 CDKN1A impairs entry to quiescence and activates a DNA damage response in normal fibroblasts induced to quiescence. Cell Cycle 2009; 8: 105-114.
50. Baker DJ, Weaver RL, van Deursen JM. p21 both attenuates and drives senescence and aging in BubR1 progeroid mice. Cell Rep 2013; 3: 1164-1174.
51. Wang Y, Sharpless N, Chang S. p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses. J Clin Invest 2013; 123: 4489-4501.
52. Fitzner B, Muller S,Walther M, et al. Senescence determines the fate of activated rat pancreatic stellate cells. J Cell Mol Med 2012; 16: 2620-30.
53. Mallen-St Clair J, Soydaner-Azeloglu R, Lee KE, et al. EZH2 couples pancreatic regeneration to neoplastic progression. Genes Dev 2012; 26: 439-444.
54. Siveke JT, Lubeseder-Martellato C, Lee M, et al. Notch signaling is required for exocrine regeneration after acute pancreatitis. Gastroenterology 2008; 134: 544-555.
55. Fukuda A, Morris JPt, Hebrok M. Bmi1 is required for regeneration of the exocrine pancreas in mice. Gastroenterology 2012; 143: 821-831, e821-822.
56. Guerra C, ColladoM, Navas C, et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011; 19: 728-739.
57. Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, et al. Molecular control of cell cycle progression in the pancreatic β-cell. Endocr Rev 2006; 27: 356-370.
58. Seleznik GM, Reding T, Romrig F, et al. Lymphotoxin β-receptor signaling promotes development of autoimmune pancreatitis. Gastroenterology 2012; 143: 1361-1374.
59. Wang Y, Guan Y, Wang F, et al. Bmi-1 regulates self-renewal, proliferation and senescence of human fetal neural stem cells in vitro. Neurosci Lett 2010; 476: 74-78.
60. Fan T, Jiang S, Chung N, et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res 2011; 9: 418-429.
61. Gu Z, Tan W, Feng G, et al. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway. Mol Cell Biochem 2014; 387: 27-37.
62. Zhang DY, Pan Y, Zhang C, et al. Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production. Mol Cell Biochem 2013; 374: 13-20.
63. Basu D, Reyes-Mugica M, Rebbaa A. Role of the β-catenin destruction complex in mediating chemotherapy-induced senescenceassociated secretory phenotype. PLoS One 2012; 7: e52188.